Is Genflow Biosciences Plc (GENF.L) a Buy, Sell, or Hold?
LSE : GENF.L
Genflow Biosciences Plc
$1.904 GBp
-$0.09 (-4.32%)
- Volume
- 60K
- Average Volume
- 1.49M
- Market Capitalization
- $10.78M
- P/E Ratio
- -5.60
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.12
- Year Low
- $0.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.45
Company Overview
LSE
Eric Leire
Biotechnology
Healthcare
GENF.L
5
GB
GBp
Liquidity Metrics
0.00
0.45
0.45
0.11
0.00
Sales & Valuation
-$
12.98
-16.23
-7.51
0.00
Profitability
-$0.0033
-$1.42M
-170.64%
-170.64%
332.06%
-313.35%
P/E Metrics
-5.60
0.07
0.07
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
-25.14
1/9
-$551.85K
$452.39K
$1M
-$1.42M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Cedric Szpirer | Head of CMC |
| Eric Jean Leire | Founder, Chief Executive Officer & Executive Director |
Poll Results
No votes yet today — be the first to share your view!
About Genflow Biosciences Plc (LSE:GENF.L) Stock
Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium. The company operates as a pre-clinical biotechnology company that focuses on developing biological interventions aimed at tackling the effects of aging, slowing, and halting the aging process, as well as reducing the incidence of age-related diseases. Its lead drug candidate is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-1003, a topical delivery of SIRT6 to the fibroblasts in the skin; GF-1004, a non-human pipeline anti-aging for veterinary use; GF-1005, which addresses mitochondrial dysfunction observed in sarcop ... enia for muscle health and combat sarcopenia; and GF-1006, an ophthalmology mRNA cent SIRT6 for the treatment of cornea pathologies and glaucoma. The company has collaborative research agreements with Revatis SA and EXO Biologics for therapy medicinal products. Genflow Biosciences plc was founded in 2020 and is headquartered in London, the United Kingdom.
Micron shares rise on Anthropic AI infrastructure partnership
2026-06-22 07:46:00
Micron Technology Inc (NASDAQ:MU) shares rose more than 4% on Monday after the company announced a strategic agreement with Anthropic covering AI...
Genflow to present beagle gene therapy data at longevity summit
2026-06-17 03:13:00
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the longevity research company, has been invited to present results from its SLAB clinical study...
Genflow surges 14% as animal health giants circle canine ageing gene therapy
2026-04-28 05:03:00
The AIM-listed biotech's SIRT6 programme is attracting a widening group of Tier-1 industry evaluators, sending shares to 2.85p. Genflow Biosciences Ltd...
Frequently Asked Questions
-
What is the current Genflow Biosciences Plc (GENF.L) stock price?
-
Genflow Biosciences Plc(LSE:GENF.L) stock price is $1.904 in the last trading session. During the trading session, GENF.L stock reached the peak price of $3.12 while $0.55 was the lowest point it dropped to. The percentage change in GENF.L stock occurred in the recent session was --4.32% while the dollar amount for the price change in GENF.L stock was -$0.09.
-
GENF.L's industry and sector of operation?
-
The LSE listed GENF.L is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of GENF.L?
-
Cedric Szpirer | Head of CMC
Eric Jean Leire | Founder, Chief Executive Officer & Executive Director
|
|
| -
How many employees does GENF.L have?
-
Number of GENF.L employees currently stands at 5. GENF.L operates from 6 Heddon Street, London, GL W1B 4BT, GB.
-
Link for GENF.L official website?
-
Official Website of GENF.L is: https://genflowbio.com
-
How do I contact GENF.L?
-
GENF.L could be contacted at phone #44 32 4774 95881 and can also be accessed through its website. GENF.L operates from 6 Heddon Street, London, GL W1B 4BT, GB.
-
How many shares of GENF.L are traded daily?
-
The average number of GENF.L shares traded daily for last 3 months was 1.49M.
-
What is the market cap of GENF.L currently?
-
The market value of GENF.L currently stands at $10.78M with its latest stock price at $1.904